Bioresorbable Polymers Market Report Scope & Overview:

Bioresorbable Polymers Market Size was valued at USD 1.49 billion in 2023. It is expected to reach USD 4.18 billion by 2031 and grow at a CAGR of 13.7% over the forecast period 2024-2031.

The growth of the bioresorbable polymers market is primarily fueled by expanding applications in medical devices and implants, driven by their biocompatibility and ability to degrade within the body. Increasing regulatory approvals for bioresorbable materials in healthcare settings further boost market demand. Growing environmental concerns and regulations promoting sustainable materials drive the adoption of bioresorbable polymers across various industries. Additionally, advancements in polymer chemistry and processing technologies enhance the performance and versatility of these materials, attracting more applications.

The growing trend towards personalized medicine and 3D printing technologies further augments the demand for bioresorbable materials, offering tailored solutions for patient-specific treatments. Moreover, the versatility of bioresorbable polymers in controlled-release systems for pharmaceuticals and agrochemicals presents new avenues for market growth and innovation.

Bioresorbable Polymers Market Trend Revenue Analysis

Get more information on Bioresorbable Polymers Market - Request Sample Report

Market Dynamics


  • Growing awareness of environmental sustainability

  • Increasing demand for biocompatible materials in medical applications

Bioresorbable materials offer a versatile array of applications in the medical field. They are utilized as surgical sutures for wound closure, scaffolds for vascular systems aiding in tissue regeneration, and fixation screws and bone pins for orthopedic procedures, ensuring stability during healing before gradually degrading. Additionally, they serve as coatings for drug delivery systems, including microspheres for targeted therapy, and as surgical meshes and matrices for tissue repair and reinforcement. This broad range of applications underscores the significant potential and versatility of bioresorbable materials in advancing medical treatments.


  • Limited mechanical strength compared to traditional polymers

  • Higher production costs associated with research and development and specialized processing techniques


  • Expanding applications beyond the medical field into packaging, agriculture, and cosmetics

  • The growing trend towards personalized medicine and 3D printing technologies

The growing trend towards personalized medicine creates opportunities for tailored bioresorbable polymer solutions, catering to individual patient needs and treatment requirements. Furthermore, the advancement of 3D printing technologies enables the fabrication of intricate bioresorbable implants and devices, offering precise customization and optimization for patient-specific applications. This convergence of personalized medicine and 3D printing presents a significant opportunity for the bioresorbable polymers market to innovate and address specific medical challenges with tailored solutions, ultimately enhancing patient outcomes and treatment effectiveness.


  • Addressing concerns about degradation kinetics and potential inflammatory responses

Addressing concerns about degradation kinetics involves optimizing the rate at which the polymer breaks down in the body to align with the healing process, avoiding premature degradation or persistence. Concurrently, managing potential inflammatory responses requires ensuring the material's biocompatibility and minimizing adverse reactions from the body's immune system, ensuring successful integration without causing harm or rejection. Balancing these factors presents a significant challenge in the development and adoption of bioresorbable polymers for medical applications.

Impact of Russia-Ukraine War:

The ongoing conflict between Russia and Ukraine has introduced significant challenges for the bioresorbable polymers market. Both nations are vital contributors to the global chemicals industry, supplying essential raw materials crucial for the production of bioresorbable polymers. With the disruption of these supply chains due to the war, there's a looming risk of shortages and subsequent price increases for these critical materials. Moreover, the conflict has triggered a surge in global energy prices, further exacerbating production costs for bioresorbable polymers. Consequently, higher production expenses may translate into elevated prices for the final bioresorbable polymer products. Additionally, the war's impact on the medical field cannot be overlooked, potentially leading to a shift in priorities away from elective medical procedures that rely on bioresorbable polymers. This redirection of resources could further strain the market's growth prospects, underscoring the far-reaching implications of the Russia-Ukraine conflict on the bioresorbable polymers industry.

Impact of Economic Downturn:

During economic downturns, the bioresorbable polymers market faces several challenges. Tightened healthcare budgets often result in decreased demand for medical devices and procedures utilizing these polymers, particularly for non-essential applications. Moreover, reduced funding availability for research and development in the sector may slow down innovation. Additionally, price sensitivity among hospitals and healthcare providers places pressure on bioresorbable polymer manufacturers to lower prices, potentially impacting their profitability. As a result, economic downturns can significantly disrupt the growth trajectory of the bioresorbable polymers market, affecting both demand and investment in the sector.

Market segmentation

By Type

  • Polylactic Acid (PLA)

  • Poly (l-lactic) acid (PLLA)

  • Poly-d,l-lactic acid (PDLLA)

  • Polysaccharides

  • Proteins

  • Polyglycolic Acid (PGA)

  • Poly (Lactic-Co-Glycolic Acid) (PLGA)

  • Polycaprolactone (PCL)

  • Others

Polylactic Acid (PLA) dominated the type segment of the Bioresorbable Polymers Market with a revenue share of more than 28% in 2023. This is primarily attributed to its widespread use across various medical applications such as surgical sutures, drug delivery systems, and tissue engineering due to its biocompatibility, biodegradability, and versatility. Moreover, PLA's eco-friendly nature aligns with growing environmental concerns, further bolstering its adoption in the market. Additionally, advancements in PLA production techniques and increasing research efforts continue to enhance its properties and expand its applications, solidifying its leading position in the bioresorbable polymers market.

By Application

  • Orthopedic Devices

  • Trauma

  • Knee

  • Sports injury

  • Hip

  • Spine

  • Others

  • Drug Delivery

  • Oral

  • Parenteral

  • Others

  • Others

Orthopedic Devices held the highest revenue share of more than 47% in 2023 in the Bioresorbable Polymers Market due to the increasing preference for bioresorbable materials in orthopedic implants due to their biocompatibility and ability to degrade over time, promoting natural tissue regeneration. The growing incidence of orthopedic injuries and disorders, coupled with advancements in material science, further fuels the demand for bioresorbable polymers in orthopedic devices. Additionally, favorable regulatory approvals and expanding applications in orthopedic surgeries contribute to this significant market share.


Get Customized Report as per your Business Requirement - Request For Customized Report

Regional Analysis

North America dominated the Bioresorbable Polymers Market with the highest revenue share of more than 33% in 2023 owing to its robust healthcare infrastructure, high adoption of advanced medical technologies, and increasing investments in research and development. Moreover, favorable government regulations promoting the use of bioresorbable materials in medical applications and the presence of key market players contribute to North America's leadership position in the market. Additionally, growing awareness about sustainable healthcare solutions further boosts the demand for bioresorbable polymers in the region.

Asia Pacific is expected to grow significantly in the Bioresorbable Polymers Market during the forecast period. This is primarily attributed to the region's rapidly expanding healthcare sector, increasing investments in research and development, and rising adoption of advanced medical technologies. Moreover, growing awareness about the benefits of bioresorbable materials, coupled with favorable government initiatives promoting their use, further fuels market expansion in the Asia Pacific. Additionally, the presence of a large patient pool and rising healthcare expenditure contribute to the region's anticipated growth in the bioresorbable polymers market.



North America

  • US

  • Canada

  • Mexico


  • Eastern Europe

    • Poland

    • Romania

    • Hungary

    • Turkey

    • Rest of Eastern Europe

  • Western Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Netherlands

    • Switzerland

    • Austria

    • Rest of Western Europe

Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Vietnam

  • Singapore

  • Australia

  • Rest of Asia Pacific

Middle East & Africa

  • Middle East

    • UAE

    • Egypt

    • Saudi Arabia

    • Qatar

    • Rest of the Middle East

  • Africa

    • Nigeria

    • South Africa

    • Rest of Africa

Latin America

  • Brazil

  • Argentina

  • Colombia

  • Rest of Latin America

Key Players:

Putnam Plastics (US), Evonik Industries AG (Germany), Ashland (US), DURECT CORPORATION (US), REVA Medical, Inc.(US, Poly-Med Inc. (US), Merck KGaA (Germany), KLS Martin (US), Corbion NV (The Netherlands), Koninklijke DSM N.V (The Netherlands), Foster Corporation. (US), Groupe PCAS (France), and other players.

Putnam Plastics (US)-Company Financial Analysis

Company Landscape Analysis

Recent Development:

  • In August 2022, Ashland made a significant announcement regarding the expansion of its Viatel™ bioresorbable polymer manufacturing and research and development site at the National Science Park in Mullingar, Ireland. This expansion is part of Ashland's strategic growth plan and will further solidify its position as a leader in the industry.

  • In December 2020, Evonik signed an agreement to acquire the LACTEL® business of biodegradable polymers from DURECT Corporation for USD 15 million. This acquisition will strengthen Evonik's position in the market and expand its portfolio of innovative products.

  • In November 2020, Foster Corporation, a leading provider of polymer solutions for medical device and pharmaceutical applications, announced a new partnership with Aran Biomedical. Aran, based in Galway, Ireland, is a global leader in biomaterial product solutions for implantable medical devices. Foster will collaborate with Aran to market their ProTEX Med*, a long-term implantable polypropylene (PP) product, showcasing the combined expertise of both companies in the industry.

Bioresorbable Polymers Market Report Scope:
Report Attributes Details
Market Size in 2023 US$ 1.49 Billion
Market Size by 2031 US$ 4.18 Billion
CAGR CAGR of 13.7% From 2024 to 2031
Base Year 2023
Forecast Period 2024-2031
Historical Data 2020-2022
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Type (Polylactic Acid (PLA), Polysaccharides, Proteins, Polyglycolic Acid (PGA), Poly (Lactic-Co-Glycolic Acid) (PLGA), Polycaprolactone (PCL), and Others)
• By Application (Orthopedic Devices, Drug Delivery, and Others)
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America)
Company Profiles Putnam Plastics, Evonik Industries AG, Ashland, DURECT CORPORATION, REVA Medical, Inc., Poly-Med Inc., Merck KGaA, KLS Martin, Corbion NV, Koninklijke DSM N.V, Foster Corporation., Groupe PCAS, and other players.
DRIVERS • Growing awareness of environmental sustainability
• Increasing demand for biocompatible materials in medical applications
Restraints • Limited mechanical strength compared to traditional polymers
• Higher production costs associated with research and development and specialized processing techniques

Frequently Asked Questions

Ans. The Compound Annual Growth rate for the Bioresorbable Polymers Market over the forecast period is 13.7%.

Ans. The projected market size for the Bioresorbable Polymers Market USD 4.18 billion by 2031.

Ans: United States dominated the North America region in the Bioresorbable Polymers Market with the highest revenue share in 2023.

Ans: The growth of the Bioresorbable Polymers Market is primarily driven by increasing demand for biocompatible materials in medical applications and growing awareness of environmental sustainability.

Ans: Challenges for the Bioresorbable Polymers Market include ensuring optimal degradation kinetics and minimizing potential inflammatory responses, as well as addressing regulatory hurdles and educating healthcare professionals and consumers about their benefits.



1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions

2. Industry Flowchart

3. Research Methodology

4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.4 Opportunities
4.4 Challenges

5. Impact Analysis
5.1 Impact of Russia-Ukraine War
5.2 Impact of Economic Slowdown
5.2.1 Introduction
5.2.2 Impact on major economies US Canada Germany France United Kingdom China Japan South Korea India

6. Value Chain Analysis

7. Porter’s 5 forces model

8. PEST Analysis

9. Average Selling Price
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East & Africa

10. Bioresorbable Polymers Market Segmentation, By Type
10.1 Introduction
10.2 Trend Analysis
10.3 Polylactic Acid (PLA)
10.3.1 Poly (l-lactic) acid (PLLA)
10.3.2 Poly-d,l-lactic acid (PDLLA)
10.4 Polysaccharides
10.5 Proteins
10.6 Polyglycolic Acid (PGA)
10.7 Poly (Lactic-Co-Glycolic Acid) (PLGA)
10.8 Polycaprolactone (PCL)
10.9 Others

11. Bioresorbable Polymers Market Segmentation, By Application
11.1 Introduction
11.2 Trend Analysis
11.3 Orthopedic Devices
11.3.1 Trauma
11.3.2 Knee
11.3.3 Sports injury
11.3.4 Hip
11.3.5 Spine
11.3.6 Others
11.4 Drug Delivery
11.4.1 Oral
11.4.2 Parenteral
11.4.3 Others
11.5 Others

12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Eastern Europe Poland Romania Hungary Turkey Rest of Eastern Europe
12.3.2 Western Europe Germany France UK Italy Spain Netherlands Switzerland Austria Rest of Western Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 India
12.4.3 Japan
12.4.4 South Korea
12.4.5 Vietnam
12.4.6 Singapore
12.4.7 Australia
12.4.8 Rest of Asia Pacific
12.5 The Middle East & Africa
12.5.1 Middle East UAE Egypt Saudi Arabia Qatar Rest of the Middle East
12.5.2 Africa Nigeria South Africa Rest of Africa
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Colombia
12.6.4 Rest of Latin America

13 Company Profile
13.1 Putnam Plastics

13.1.1 Company Overview
13.1.2 Financials
13.1.3 Product/Services Offered
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 Evonik Industries AG
13.2.1 Company Overview
13.2.2 Financials
13.2.3 Product/Services Offered
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Ashland
13.3.1 Company Overview
13.3.2 Financials
13.3.3 Product/Services Offered
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4.1 Company Overview
13.4.2 Financials
13.4.3 Product/Services Offered
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 REVA Medical, Inc.
13.5.1 Company Overview
13.5.2 Financials
13.5.3 Product/Services Offered
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 Poly-Med Inc.
13.6.1 Company Overview
13.6.2 Financials
13.6.3 Product/Services Offered
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 Merck KGaA
13.7.1 Company Overview
13.7.2 Financials
13.7.3 Product/Services Offered
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 KLS Martin
13.8.1 Company Overview
13.8.2 Financials
13.8.3 Product/Services Offered
13.8.4 SWOT Analysis
13.8.5 The SNS View
13.9 Corbion NV
13.9.1 Company Overview
13.9.2 Financials
13.9.3 Product/ Services Offered
13.9.4 SWOT Analysis
13.9.5 The SNS View
13.10 Koninklijke DSM N.V.
13.10.1 Company Overview
13.10.2 Financials
13.10.3 Product/Services Offered
13.10.4 SWOT Analysis
13.10.5 The SNS View
13.11 Foster Corporation
13.11.1 Company Overview
13.11.2 Financials
13.11.3 Product/Services Offered
13.11.4 SWOT Analysis
13.11.5 The SNS View
13.12 Groupe PCAS
13.12.1 Company Overview
13.12.2 Financials
13.12.3 Product/Services Offered
13.12.4 SWOT Analysis
13.12.5 The SNS View

14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments
14.3.1 Industry News
14.3.2 Company News
14.3.3 Mergers & Acquisitions

15. USE Cases and Best Practices

16. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone